| DC Field | Value | Language |
|---|
| dc.contributor.author | Termulaeva, R. M. | - |
| dc.contributor.author | Belanov, K. V. | - |
| dc.contributor.author | Bunyatyan, N. D. | - |
| dc.contributor.author | Pirozhkov, A. S. | - |
| dc.contributor.author | Timoshkin, D. E. | - |
| dc.date.accessioned | 2024-11-12T14:01:13Z | - |
| dc.date.available | 2024-11-12T14:01:13Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Ascorbic acid-containing compound efficacy in ischemic brain damage / R.M. Termulaeva, K.V. Belanov, N.D. Bunyatyan [et al.] ; Kadyrov Chechen State University // Research Results in Pharmacology. - 2024. - Vol.10, №3.-P. 25-32. - Doi: 10.18413/rrpharmacology.10.508. - Refer.: p. 30-31. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63922 | - |
| dc.description.abstract | The aim: to assess anti-ischemic activity of 3-hydroxypyridine ascorbate in the in vitro and in vivo models of brain cell and tissue response to ischemia and reoxygenation | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | 3-hydroxypyridine ascorbate (3-EA) | ru |
| dc.subject | ischemia | ru |
| dc.subject | brain damage | ru |
| dc.subject | cell culture | ru |
| dc.subject | cerebral artery occlusion | ru |
| dc.subject | Ca2+ | ru |
| dc.subject | neurological deficits | ru |
| dc.title | Ascorbic acid-containing compound efficacy in ischemic brain damage | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 3
|
